Svetovna zdravstvena organizacija (WHO) zdaj beleži slabih 60 tisoč obolelih za novo gripo H1N1, 263 ljudi je zaradi nje umrlo. Inštitut za varovanje zdravja (IVZ) sporoča, da vsi trije Slovenci, ki so zboleli za novo gripo, okrevajo, novih primerov pa niso zabeležili. Ameriška farmacevtska družba Baxter in švicarska farmacevtska družba Novartis sta objavili, da sta že začeli proizvajati cepivo proti novi gripi, ki bo na voljo najbrž julija. Tudim druge farmacevtske družbe, GlaxoSmithKline, Sanofi-Aventis in Solvay, imajo naročila za proizvodnjo novega cepiva. Baxter je še sporočil, da so evropski regulatorji že potrdili vzorec cepiva, ki je predvideno za uporabo v primeru pandemije, na podlagi tega bo za cepivo mogoče hitro izdati dovoljenje za uporabo, je poročal Wall Street Journal.
WHO je sporočila, da bo skupaj z nacionalnimi regulatornimi organi zagotovila, da bo cepivo za novo gripo, ki jo povzroča virus H1N1, izpolnjevalo vse pogoje glede varnosti, farmacevtskim družbam pa ne priporoča, naj prenehajo proizvajati cepivo za sezonsko gripo. Za navadno sezonsko gripo namreč na leto zboli 3 do 5 milijonov ljudi, od tega jih med 25o tisoč in 500 tisoč umre. Zaradi tega je treba tudi zanjo zagotoviti cepivo. Poleg tega po oceni WHO ne bi mogli hitreje proizvajati cepiva proti gripi H1N1, če bi povsem prenehali izdelovati cepivo za sezonsko gripo.
Blizu 90 odstotkov tovarn za proizvodnjo cepiva proti gripi je v Evropi in Severni Ameriki, prav tako je precej tovarn v Avstraliji in na Japonskem. A v WHO pravijo, da so od proizvajalcev zahtevali, da morajo do 400 milijonov odmerkov cepiva za novo gripo zagotoviti za agencijo za javna naročila pri OZN, da bi zagotovili čim boljšo dostopnost tudi ljudem v manj razvitih državah.
Tisti, ki jih zanima denar, pa so že začeli računati, kdo bo s pandemijo zaslužil in kdo bo na izgubi, je že konec aprila poročal Chicago Tribune. Med tistimi z dobičkom bodo gotovo farmacevtske družbe, saj bodo zaskrbljene vlade hotele imeti čim več zalog protivirusnih zdravil in celo cepiva, ki sploh še nima dovoljenja za široko uporabo. Roche, ki prodaja zdravilo tamiflu, je lani recimo početveril prodajo na 1,6 milijarde dolarjev, od tega mu je 800 milijonov dolarjev prinesla “prodaja zaradi pandemije”.
“The markets are anticipating it, and there are already investors making bets on the potential that there will be a pandemic,” said Paul Heldman, senior health policy analyst for Citigroup in Washington.
/…/
To be sure, health-care companies are benefiting from worried governments looking to stockpile antiviral drugs and even vaccines that have not yet been commercially approved for wide use in humans. One commercially available antiviral drug that is seen as effective in treating avian flu after it infects humans has been a sales boon to its maker. Sales of Roche AG’s Tamiflu drug quadrupled last year to $1.6 billion, largely thanks to nearly $800 million in what the company calls “pandemic sales.”
V ZDA se tudi sprašujejo, ali je obvezno cepljenje proti novi gripi v skladu z ustavo in opozarjajo na zaskrbljive stranske učinke in posledice.
According to Matsumoto, today, “Squalene adjuvants are a key ingredient in a whole new generation of vaccines intended for mass immunization around the globe” even though researchers at Tulane Medical School and the Walter Reed Army Institute of Research proved “that the immune system responds specifically to the squalene molecule.”
/…/
There is squalene in the prototype recombinant vaccines for HIV, malaria, herpes, influenza (including the swine strain), cytomegalovirus and human papillomavirus.” Some of these “are intended for mass immunization(s) around the globe” and that possibility should terrify everyone enough to refuse any mandate or doctor’s prescription to take them.
Another problem is that “Autoimmunity (takes) years to diagnose” because early symptoms (headaches, joint pain, etc.) are so vague they can easily be from other causes.
From inception, vaccines have always been dangerous enough for some experts to call them biological weapons undermining health, manipulating and crippling the immune system, and creating the possibility of future debilitating diseases. So Big Pharma’s solution is new, more potent genetically engineered vaccines and drugs that may end up harming or killing many who take them, especially people with weakened immune systems.
V Evropi ima načrt za cepljenje državljanov po pisanju Journal du Dimanche očitno Francija.
...
